Endo Pharmaceuticals Solutions 10K 2004 Annual report | IDEV Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: accuracy, aimed, ALZA, amenable, anniversary, Ascending, aspirin, asymptomatic, bacterium, bear, bearing, Beerman, bound, brand, branded, category, CEO, children, concept, constipation, contemplating, contractility, Creative, crossed, customer, Darden, daytime, differentiating, discomfort, disruption, doubtful, dramatic, earliest, ECG, elapsed, electrophysiology, element, Elmiron, escitalopram, etiology, experimentation, explain, explained, feasibility, fewer, field, FIFO, fleet, focused, focusing, Fordham, Forest, formal, formally, frequent, frequently, fulfilling, fulfillment, fur, gastric, glaucoma, gynecology, Hampshire, highest, hired, histamine, Holy, HPTN, hundred, hypersensitivity, ibuprofen, IL, IMS, incidental, infrastructure, insert, inspector, interstitial, interval, inversion, invoiced, IVAX, John, justified, Kline, Lexapro, matrix, MDP, median, mitigating, molecular, moxifloxacin, narcotic, Network, Noah, Northeastern, nutritional, OAB, Odyssey, opportunity, Oversight, PDUFA, pediatric, pentosan, peroxisome, pharmacodynamic, plasma, pliva, Plymouth, polysulfate, predetermined, procurement, Programme, proof, QT, Raw, recur, reevaluate, regularly, reliable, relieving, rental, Repligen, Rochester, sample, SANCTURA, Sandoz, serum, shipment, Similarly, Smith, sodium, specialist, specialty, speech, SSS, staffing, stand, stemming, stipulated, stutter, stuttering, sublicencee, subsidy, superseding, tension, title, TMF, toilet, Tucker, twelfth, UCB, undelivered, undistributed, unknown, Urogynecological, User, vehicle, venture, vii, Virginia, visiongain, visit, vocal, ware, XR

Removed: accumulation, acetylcholine, Activase, afflicted, artery, auditing, breakdown, broadly, Canadian, Casualty, choline, clogged, Columbia, comparative, contrast, cytidine, cytochrome, damaged, death, deferral, deliver, denominator, diary, diligent, discontinued, endpoint, essential, excreted, factor, fatty, financed, formation, functional, Genentech, German, inadequate, infarct, insolvency, interaction, interleukin, interrupted, Japanese, Junemann, lawsuit, learning, life, membrane, memory, metabolized, moderate, naturally, neuromuscular, Neurourol, North, occurring, oxidation, oxygen, packaging, penumbra, pertained, pertaining, pharmacotherapy, phospholipid, priority, prospectively, reacquired, realization, reconciliation, rehabilitation, rejected, residual, restore, retroactive, reversal, reversed, statistical, sublicensing, supportive, terminating, toxic, unchanged, unsatisfied, Urodyn, urodynamic, withdrew, yield


Name of Subsidiary		State of Incorporation
CPEC LLC		Deleware
InterNutria, Inc.		Deleware

Endo Pharmaceuticals Solutions (IDEV) Inactive 10-K2004 FY Annual report

Content analysis